FirstRanker Logo

FirstRanker.com - FirstRanker's Choice is a hub of Question Papers & Study Materials for B-Tech, B.E, M-Tech, MCA, M.Sc, MBBS, BDS, MBA, B.Sc, Degree, B.Sc Nursing, B-Pharmacy, D-Pharmacy, MD, Medical, Dental, Engineering students. All services of FirstRanker.com are FREE

📱

Get the MBBS Question Bank Android App

Access previous years' papers, solved question papers, notes, and more on the go!

Install From Play Store

Download RGUHS M.ch 9378 Gynaecological Oncology Paper III 2019 July Question Paper

Download RGUHS (Rajiv Gandhi University of Health Sciences) M.ch (Master of Surgery) 2019 July 9378 Gynaecological Oncology Paper III Previous Question Paper

This post was last modified on 03 June 2022

RGUHS M.ch Last 10 Years 2011-2021 Previous Question Papers || Rajiv Gandhi University of Health Sciences


FirstRanker.com

Rajiv Gandhi University of Health Sciences

M.Ch Degree Examination - JULY-2019

--- Content provided by‍ FirstRanker.com ---

Time: Three Hours Max. Marks: 100 Marks

GYNAECOLOGICAL ONCOLOGY - PAPER - III

Allied Specialities of Gynaecologic Oncology

QP Code: 9378

Your answers should be specific to the questions asked.

--- Content provided by‌ FirstRanker.com ---

Draw neat, labeled diagrams wherever necessary. Answer all questions

LONG ESSAY (These questions carry 10 marks each) 10 x 10 = 100 Marks

  1. Molecular characterization of endometrial cancers and its therapeutic implications.
  2. Discuss genetic mutations, the role of genetic counselling and gene therapy in the management of Gynaecological malignancies.
  3. What is the role of minimally invasive surgery in Cervical, Endometrial and ovarian cancers?
  4. --- Content provided by FirstRanker.com ---

  5. Discuss the approach to evaluation of suspicious adnexal mass.
  6. Critically evaluate the role of PET-CT in Gynaecological malignancies.
  7. Discuss LILACS study. Discuss and evaluate the role of lymphadenectomy in advance cervical cancer and its impact on morbidity and outcome.
  8. Newer tumor biomarkers for ovarian carcinoma.
  9. Describe phases of drug of development trials. How is the monitoring of tumor response done by RECIST criteria?
  10. --- Content provided by‍ FirstRanker.com ---

  11. Recent advances in the management of the uterine sarcomas.
  12. What are the recent advances in HPV vaccines and their clinical implications?

FirstRanker.com

*****


--- Content provided by​ FirstRanker.com ---


This download link is referred from the post: RGUHS M.ch Last 10 Years 2011-2021 Previous Question Papers || Rajiv Gandhi University of Health Sciences